Medical derm

Discussion in 'Sun Pharma' started by anonymous, Sep 20, 2019 at 10:54 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    HAHAHAHA
     

  2. anonymous

    anonymous Guest

    I think everyone is certainly thankful for having their jobs during these times. But these issues were around much before COVID-19 was present. Bonuses are not guaranteed but is what makes a SALES JOB! Many are lied to of the potential or lack there of. Turnover, management issues, lack of departments communicating, and overall communication are a mess.
     
  3. anonymous

    anonymous Guest

    So he’s living at his dads house in Florida, in a state that is surging in cases and has the audacity to say all offices are open. The environment has changed. Adapt or get eaten
     
  4. anonymous

    anonymous Guest

    Get ready for flip charts, role plays, people being off mute, and a disaster of presentations on these upcoming “light kindling LD fire” sessions. Complete waste of time
     
  5. anonymous

    anonymous Guest

    how much money does LD bring in compared to Absorica? Is the per script amount the same. I
     
  6. anonymous

    anonymous Guest

    I am unsure to your question but from a management prospective right now it doesn’t matter. They are profiting by having 2 options. The problem lies when Absorica goes generic. Many docs aren’t moving over as insurance is not optimal. LD May never reach the heights expected and fill the void it was expected.
     
  7. anonymous

    anonymous Guest

    LD makes more per script. But because it is harder to sell, idiot reps will always take the easy road out. You may make some decent money now, but not converting to LD over time will certainly cause big problems down the road.
     
  8. anonymous

    anonymous Guest

    "But because it is harder to sell, idiot reps will always take the easy road out. You may make some decent money now, but not converting to LD over time will certainly cause big problems down the road"

    idiot reps will take the easy road out???? the reps have no choice. Its sell LD or get $0 in commission. Absorica is being filled 9.99999/10 while LD is getting filled .00000001/10. reps want LD to take over as first in line but derms and pharmacies aren't buying it. You have no idea what is going on.
     
  9. anonymous

    anonymous Guest

    Honest opinion: will LD be able to achieve the market share that Absorica has? What happens once it goes Generic. Will the launch of Solution be prevalent to sustain our division?
     
  10. anonymous

    anonymous Guest

    no....increased pain and market share loss...solution is a joke, Trump says only better if you can drink it
     
  11. anonymous

    anonymous Guest

    No. The future is Grim. LD has been a complete flop from launch, marketing and market access. Once this goes Generic, it’s probably game over. Solution- seems like a good product, but it’s revenue can’t float the division
     
  12. anonymous

    anonymous Guest

    Tick tock, tick tock, when’s the clock gonna stop?
     
  13. anonymous

    anonymous Guest

    well im in the top 20 of LD sales yet going to make less than i was making on the CF? Yeah im leaving. Not even going to pay for 1 week of childcare...
     
  14. anonymous

    anonymous Guest

    This place is a joke - we couldn’t launch a (fill in the blank)
    Seriously, fill in the blank ...
     
  15. anonymous

    anonymous Guest


    If you can’t live off your base then your doing something wrong.
     
  16. anonymous

    anonymous Guest

    great point but when you have several kids, medical bills, Mortgage and a husband who was laid off it begins to get very tight
     
  17. anonymous

    anonymous Guest

    Another top performer leaving. We’re not at about 20% turnover since the arrival of BJ
     
  18. anonymous

    anonymous Guest

    Who left? Initials?
     
  19. anonymous

    anonymous Guest

    Chirp chirp chirp...theres some chatter
     
  20. anonymous

    anonymous Guest

    why is Phoenix open? Promotion?